Durkin Bryan T

Director Bryan T Durkin sold 4,200 CME shares at $309.65; current price $314.00 near 52-week high.

Durkin sold 4,200 shares (8.9% of his pre-transaction holdings) at $309.65 on 2026-02-23, when CME was trading +0.0% from its 52-week high of $314.00. His remaining position is 43,007 shares. At the same ticker, his 1 of 2 prior sells were well-timed at the 90-day mark, though his cross-ticker track record shows an average 90-day return of +4.5% after prior sells, indicating mixed timing outcomes historically. CME's fundamentals remain solid: the company reported revenue of $1,537,600,000.00 in the latest quarter with net income of $908,000,000.00, and the stock has appreciated +11.1% over the past 30 days and +13.4% over 90 days. The sale occurred at a price near recent highs in a rally, but without additional context on scheduling or strategic intent, this represents a routine portfolio transaction.

Director Bryan T Durkin sells 7,593 CME shares at $214.59 for $1.6M; holds 55.1K shares post-sale.

Bryan T Durkin, a CME director, sold 7,593 shares at $214.59 on 2024-08-30, reducing his stake by 12.1% from 62,735 shares to 55,142 shares. His cross-ticker track record shows 1 prior sell with a 90-day well-timed rate of 100.00%, and his prior CME sale on 2023-12-11 also registered -1.6% 90-day return, consistent with sales executed ahead of subsequent declines. The current stock price of $212.64 is 3.9% below the 52-week high of $221.35, and the 30-day change of +6.4% suggests recent upward momentum. CME's fundamentals remain strong with quarterly revenue of $1,532,500,000.00, net income of $883,200,000.00, and annual revenue growth of +11.2%, alongside a low P/E of 4.34. The sale represents a partial position reduction rather than an exit, and occurs at a price near recent highs relative to the 52-week range.